Metabolic Syndrome In Thyroid Disease

Preview this chapter:

Metabolic Syndrome In Thyroid Disease, Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9789815322132/chapter-23-1.gif

Thyroid diseases significantly influence metabolic parameters, including blood pressure regulation, glucose metabolism, obesity, hyperlipidemia, and nonalcoholic fatty liver disease (NAFLD). Hypothyroidism is often linked to hypertension, insulin resistance, and dyslipidemia, while hyperthyroidism may induce weight loss, insulin resistance, and dyslipidemia. Both hypo- and hyperthyroidism impact blood pressure regulation, glucose homeostasis, and adiposity. Dyslipidemia is frequently observed in thyroid disorders, with hypothyroidism associated with elevated cholesterol levels and hyperthyroidism with altered lipid profiles. Additionally, thyroid dysfunction contributes to the development of NAFLD. There is a close relationship between thyroid hormones and metabolic syndrome components, as well as the development of metabolic syndrome.